Home » Authors » Jennifer Boggs

Articles by Jennifer Boggs

Targacept NNR Platform Lands In Billion-Dollar GSK Alliance

July 30, 2007

By Jennifer Boggs

Targacept Inc. got an impressive stock boost Friday, jumping 20 percent on an early stage deal with GlaxoSmithKline plc to develop drugs targeting neuronal nicotinic receptors for pain and other disorders. (BioWorld Today)

Targacept NNR Platform Lands In Billion-Dollar GSK Alliance

July 30, 2007

By Jennifer Boggs

Targacept Inc. got an impressive stock boost Friday, jumping 20 percent on an early stage deal with GlaxoSmithKline plc to develop drugs targeting neuronal nicotinic receptors for pain and other disorders. (BioWorld Today)

Exelixis Moving Forward On XL647 After GSK Declines

July 27, 2007

By Jennifer Boggs

Exelixis Moving Forward On XL647 After GSK Declines

July 27, 2007

By Jennifer Boggs

Imarx Goes Public With $15M Offering; Archemix Files For IPO

July 26, 2007

By Jennifer Boggs

Imarx Goes Public With $15M Offering; Archemix Files For IPO

July 26, 2007

By Jennifer Boggs

Orexigen's Weight Loss Drug Shows Promise In Phase IIb

July 25, 2007

By Jennifer Boggs

Orexigen's Weight Loss Drug Shows Promise In Phase IIb

July 25, 2007

By Jennifer Boggs

Horizon's 'GI-Friendly' NSAID Work Backed By $30M Series C

July 24, 2007

By Jennifer Boggs

Horizon's 'GI-Friendly' NSAID Work Backed By $30M Series C

July 24, 2007

By Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Wuxi Apptec insists it’s ‘not a Chinese military company’
BioWorld
Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...
Researchers hit back after colleagues removed from ADA meeting
BioWorld
Former principal officers of the American Diabetes Association (ADA) have hit back at the association’s board and CEO after it prohibited the distribution of an...